Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Massignan

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Methods (San Diego, Calif.)|December 1, 2010
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guideTania Massignan, Emiliano Biasini, David A Harris
The Biochemical Journal|July 15, 2010
The hydrophobic core region governs mutant prion protein aggregation and intracellular retentionEmiliano Biasini, Laura Tapella, Elena Restelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomicsTeresa Laragione, Valentina Bonetto, Filippo Casoni, et al.
The Journal of Biological Chemistry|March 10, 2011
An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicityIsaac H Solomon, Natasha Khatri, Emiliano Biasini, et al.
The Journal of Biological Chemistry|February 9, 2005
Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesisFilippo Casoni, Manuela Basso, Tania Massignan, et al.
The Journal of Biological Chemistry|September 1, 2006
Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis miceManuela Basso, Tania Massignan, Giuseppina Samengo, et al.
The Journal of Biological Chemistry|November 27, 2009
A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion proteinTania Massignan, Richard S Stewart, Emiliano Biasini, et al.
Proteomics|March 31, 2006
Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activityEmiliano Biasini, Tania Massignan, Luana Fioriti, et al.
Biological Chemistry|November 4, 2006
Regulation of redox-sensitive exofacial protein thiols in CHO cellsTeresa Laragione, Elisabetta Gianazza, Rossella Tonelli, et al.
Plos One|March 20, 2012
The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cellsEmiliano Biasini, Jessie A Turnbaugh, Tania Massignan, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Methods (San Diego, Calif.)|December 1, 2010
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guideTania Massignan, Emiliano Biasini, David A Harris
The Biochemical Journal|July 15, 2010
The hydrophobic core region governs mutant prion protein aggregation and intracellular retentionEmiliano Biasini, Laura Tapella, Elena Restelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomicsTeresa Laragione, Valentina Bonetto, Filippo Casoni, et al.
The Journal of Biological Chemistry|March 10, 2011
An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicityIsaac H Solomon, Natasha Khatri, Emiliano Biasini, et al.
The Journal of Biological Chemistry|February 9, 2005
Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesisFilippo Casoni, Manuela Basso, Tania Massignan, et al.
The Journal of Biological Chemistry|September 1, 2006
Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis miceManuela Basso, Tania Massignan, Giuseppina Samengo, et al.
The Journal of Biological Chemistry|November 27, 2009
A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion proteinTania Massignan, Richard S Stewart, Emiliano Biasini, et al.
Proteomics|March 31, 2006
Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activityEmiliano Biasini, Tania Massignan, Luana Fioriti, et al.
Biological Chemistry|November 4, 2006
Regulation of redox-sensitive exofacial protein thiols in CHO cellsTeresa Laragione, Elisabetta Gianazza, Rossella Tonelli, et al.
Plos One|March 20, 2012
The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cellsEmiliano Biasini, Jessie A Turnbaugh, Tania Massignan, et al.
Pageof 3